Pharmaceutical Contract Manufacturing Organization

Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients’ needs.

Your Partner for Nasal Sprays

State-of-the-art laboratory

Cutting edge spray characterization instruments, almost 20 years in nasal experience, and successful commercialization of products for the US and global markets, Renaissance is the “one-stop-shop” for all your nasal spray formulation, development, testing, and commercialization needs.

LEARN MORE

Trusted, Reliable Contract Manufacturing

World-class sterile liquid manufacturing

Renaissance is a global, pure-play contract development and manufacturing organization (“CDMO”) leader with an unparalleled bench-to-shelf service offering for nasal and sterile injectable dosage forms.

LEARN MORE

1979

Where it all started. Paco Packaging & Labs relocates to Paco Way in Lakewood, NJ from Philadelphia, PA.

LEARN MORE
pharmaceutical vials on assembly line
Trusted & Reliable Manufacturing

Our Capabilities Overview

Watch Video

News & Events

Our newest offerings and capabilities. Recent investments in our facilities, new and expanded services and expertise. Upcoming conferences and events.
Press

September 30, 2024

Renaissance Lakewood, LLC Supports ARS Pharmaceuticals, Inc.’s Launch of World’s First Nasal Spray for Life-Threatening Allergies

Renaissance Lakewood, LLC (“Renaissance”), a leading global contract development and manufacturing organization (“CDMO”) is proud to be manufacturing neffy®, which is now commercially available in the US.

READ MORE
Press

September 3, 2024

RENAISSANCE LAKEWOOD, LLC ANNOUNCES COMPLETION OF CAMPUS ENHANCEMENT PROJECT

Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ.

READ MORE
Edinburgh International Conference Centre
Events

August 28, 2024

DDL 2024 – Drug Delivery to the Lungs Conference

Premier International Pulmonary & Nasal Drug Delivery Conference at The Edinburgh International Conference Centre – The Exchange in Edinburgh, Scotland, December 11 – December 13, 2024

READ MORE

+$30m

+$30 million in facilities and equipment investments since 2020

1st

Manufacturer of the first FDA approved bi-dose nasal spray drug

310k

Sq. ft. of infrastructure with additional space under construction

+10

cGMP manufacturing suites with additional under construction